Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734875 | SCV000863053 | pathogenic | not provided | 2018-08-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855821 | SCV002240164 | pathogenic | Jeune thoracic dystrophy | 2024-02-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr2715*) in the DYNC2H1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYNC2H1 are known to be pathogenic (PMID: 23339108, 32753734, 33755199). Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This premature translational stop signal has been observed in individual(s) with asphyxiating thoracic dystrophy and/or short rib-polydactyly syndrome (PMID: 29068549; Invitae). ClinVar contains an entry for this variant (Variation ID: 598476). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005047007 | SCV005678337 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | 2024-05-21 | criteria provided, single submitter | clinical testing |